CClinicalTrials.gg
CompletedNCT05552014Updated Jul 10, 2026

Study on the Efficacy Mechanism of Natural Psychotherapy for Neurosis

An interventional study of Natural Psychotherapy and waitlist control group in Obsessive-Compulsive Disorder, sponsored by Beijing HuiLongGuan Hospital. Completed at 2 sites in China. Open to participants aged 16 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-10.

Sponsored by Beijing HuiLongGuan Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
16 Years to 55 Years
Sex
All
01

Study summary

explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder

Read the detailed description
  1. To evaluate the cognitive function, Cognitive control, emotion and other aspects of neurosis patients, and to understand and master the cognitive behavior indicators of this population.
  2. Investigate the pathological mechanism of neurotic patients from the aspects of EEG/fMRI and biology.
  3. To investigate the therapeutic effect of natural psychotherapy on cognitive impairment and related mood, sleep and symptom intervention in neurotic patients. In order to achieve the symptoms of neurosis patients, cognitive impairment and related mood and sleep intervention and promotion, while providing a scientific basis for neurosis rehabilitation.
02

Conditions studied

  • Obsessive-Compulsive Disorder

Keywords

  • obsessive-compulsive disorder
  • natural psychotherapy
03

Who can participate

Ages eligible
16 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • were between 16 and 55 years old;
  • were diagnosed with OCD by an experienced psychiatrist utilizing the Structured Clinical Interview for DSM-5 (SCID);
  • had an illness duration of at least 12 months;
  • were able to participate in the entire trial and face-to-face on-site assessment

Exclusion criteria

Exclusion Criteria:

  • pregnant or breastfeeding;
  • suffered from organic brain diseases or severe physical illness;
  • had a history of substance or alcohol abuse
  • were at high risk of suicide
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (actual)

Study arms

  • Active comparator
    Natural Psychotherapy

    Intervention using natural psychotherapy for OCD patients for two to three hours once a week for eight weeks

    Behavioral: Natural Psychotherapy

  • Other
    waitlist control group

    The waiting group will not undergo any intervention adjustments within the next two months and will not receive any other psychological interventions.

    Behavioral: waitlist control group

Interventions

  • BehavioralNatural Psychotherapy

    Natural psychotherapy is based on "Morita therapy" and is a psychotherapy that fully reflects the characteristics of Chinese culture, taking into account the Chinese cultural background and actual clinical characteristics.

  • Behavioralwaitlist control group

    waitlist control group

05

What researchers measure

Primary outcomes

  1. Obsessive-compulsive symptoms

    Using the score of Yale-Brown Obsessive-Compulsive Scale as the primary outcome, a decrease in score of ≥35% was considered a 'response to treatment', also referred to as a 'full response', and a decrease in score of ≥25% was considered a 'partial response'

    Time frame: Baseline, week 4, week 8

Secondary outcomes

  1. Self-reported obsessive-compulsive symptoms

    The reduction rate of the score of Obsessive-Compulsive Inventory-Revised (OCI-R), a self-rating scale of OCD symptoms severity, was employed as a secondary outcome

    Time frame: Baseline, week 4, week 8

  2. Cognitive inhibition

    Cognitive inhibition was assessed using the emotional color-word Stroop task. The emotional Stroop task is a type of being Widely used cognitive inhibition assessment tools. The longer the reaction time, the worse the cognitive inhibition ability.

    Time frame: Baseline, week 8

  3. Behavioral inhibition

    Behavioral inhibition was assessed using the emotional stop signal task (SST). The emotional SST task is a type of being Widely used behavioral inhibition assessment tools. Among them, the greater the SSRT, the worse the behavioral inhibition ability.

    Time frame: Baseline, week 8

  4. ERP components associated with cognitive function

    To explore the ERP component analysis related to cognitive inhibition and Behavioral inhibition in obsessive-compulsive disorder (OCD) by event related potential (ERP) analysis

    Time frame: Baseline, week 8

  5. rest fMRI in Obsessive-compulsive patients

    The changes of resting-state functional connectivity were analyzed in patients with OCD before and after intervention. Resting-state functional connectivity:FC(Functional connectivity). Resting-state functional brain imaging data were collected using a GE 3.0T magnetic resonance scanner (GE Discovery MR750) at the Brain Imaging Center, Institute of Psychology, Chinese Academy of Sciences.

    Time frame: Baseline, week 8

06

Study locations

2 sites
  • Anhui Mental Health Center
    Hefei, Anhui 230022, China
  • Institute of Psychology, Chinese Academy of Sciences
    Beijing, China 100096, China
07

References and documents

Individual participant data

Plan to share: No — Data with be available on request

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05552014
Lead sponsor
Beijing HuiLongGuan Hospital
Responsible party
Xiang Yang Zhang (Professor, Beijing HuiLongGuan Hospital) — Principal investigator
First posted
Sep 23, 2022
Start date
May 1, 2022
Primary completion
Dec 1, 2025
Completion
Dec 1, 2025
Last update
Jul 10, 2026

Study contacts

Xiang Y Zhang, M.D, Ph.D
principal investigator · Institute of Psychology, Chinese Academy of Science

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion